Cidara Therapeutics Inc (NASDAQ:CDTX)
| 1.69 Delayed Data As of Feb 06 |  +0.21 / +13.91%Today’s Change | 0.40 Today|||52-Week Range 1.74 | +123.46% Year-to-Date |
Latest CDTX News | Press Releases
No recent news for Cidara Therapeutics Inc.
Today’s Trading
| Previous close | 1.51 |
| Today’s open | 1.64 |
| Day’s range | 1.46 - 1.74 |
| Volume | 3,627,534 |
| Average volume (3 months) | 932,075 |
| Market cap | $108.1M |
Data as of 4:00pm ET, 02/06/2023
Growth & Valuation
| Earnings growth (last year) | +55.06% |
| Earnings growth (this year) | +48.56% |
| Earnings growth (next 5 years) | +47.10% |
| Revenue growth (last year) | +310.81% |
| P/E ratio | NM |
| Price/Sales | 1.34 |
| Price/Book | 4.75 |
Competitors
Data as of 3:59pm ET, 02/06/2023
Financials
| Next reporting date | March 1, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $49.6M |
| Annual profit (last year) | -$42.5M |
| Net profit margin | -85.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
